Dr. Ricky Turgeon received his BSc(Pharm) in 2012 from the Dalhousie University College of Pharmacy, his Pharmacy Residency from the Lower Mainland Pharmacy Services Residency Program in 2013, and his PharmD in the Faculty of Pharmaceutical Sciences at UBC in 2015. He then completed a two-year post-doctoral fellowship at the University of Alberta Faculty of Medicine & Dentistry (Division of Cardiology) in 2018. Currently, Dr. Turgeon is assistant professor (tenure-track) at the UBC Faculty of Pharmaceutical Sciences; and clinical pharmacy specialist in the PHARM-HF (Pharmacist-led optimization of pharmacotherapy for heart failure) clinic at St. Paul's Hospital.
Dr. Turgeon’s research focuses on integrating high-quality observational studies and meta-analyses of clinical studies to guide the creation and evaluation of decision support tools and other knowledge translation strategies to ensure that pharmacotherapy for cardiovascular disease align with patient goals, preferences and values. His research focuses include heart failure pharmacotherapy, antithrombotic agents, lipid-lowering therapies, and on the cardiovascular safety of medications.